Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ADA | P00813 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.49 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.49 |
| ▸ | SRC | P12931 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.49 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.49 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.49 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | FBP1 | P09467 | 1/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.49 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.49 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22990586 | 1.00 | BCHE (0.51) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20225033 | 1.00 | BCHE (0.51) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20691945 | 0.90 | BCHE (0.50) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20691455 | 0.90 | BCHE (0.50) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20663978 | 0.89 | BCHE (0.51) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20224908 | 0.89 | BCHE (0.51) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL18837728 | 0.89 | P2RY1 (0.62) | POLBENPP1P2RY1P2RY2SRC | |
| SCHEMBL22842814 | 0.89 | BCHE (0.51) | BCHEADAPOLBENPP1P2RY1 | |
| SCHEMBL20959779 | 0.89 | P2RY1 (0.62) | POLBENPP1P2RY1P2RY2SRC | |
| SCHEMBL20225051 | 0.89 | P2RY1 (0.62) | POLBENPP1P2RY1P2RY2SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1461455-A2 | POST-SYNTHESIS LABELING OF NUCLEIC ACIDS AND USES THEREOF | Amersham Biosciences AB (SE) | 2004-09-29 | — | — | EP | claimed |
| WO-2003052115-A2 | POST-SYNTHESIS LABELING OF NUCLEIC ACIDS AND USES THEREOF | AMERSHAM BIOSCIENCES AB (SE) | 2003-06-26 | — | — | WO | claimed |
| US-20030119005-A1 | Post-synthesis labeling of nucleic acids, assays using nucleic acids that are labeled post-synthetically, single nucleotide polymorphism detection, and associated compounds and microarrays | MOTOROLA, INC. | 2003-06-26 | — | — | US | claimed |
| EP-3512861-B1 | CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS | TAKEDA PHARMACEUTICALS CO (JP) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020246443-A1 | PRODUCTION METHOD FOR BIFURCATED LIPID-LINKED OLIGONUCLEOTIDE, AND INTERMEDIATE | 塩野義製薬株式会社 | 2020-12-10 | — | — | WO | disclosed |
| WO-2020205323-A1 | STABLE FORMULATIONS OF CYCLIC DINUCLEOTIDE STING AGONIST COMPOUNDS AND METHODS OF USE THEREOF | MERCK SHARP & DOHME CORP. (US) | 2020-10-08 | — | — | WO | disclosed |
| WO-2018118665-A1 | CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT | MERCK SHARP & DOHME CORP. (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018100558-A2 | CYCLIC DINUCLEOTIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-07 | — | — | WO | disclosed |
| WO-2011005595-A2 | 2-5A ANALOGS AND THEIR METHODS OF USE | ALIOS BIOPHARMA, INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| EP-0731846-B1 | NUCLEOSIDE ANALOGUE METHOD | AMERSHAM PHARM BIOTECH UK LTD (GB) | 1999-03-03 | — | — | EP | disclosed |